Ondine Biomedical Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	10.57	9.77	2.98	13.13	30.37
Cash & Short-Term Investments	10.57	9.77	2.98	13.13	30.37
Cash Growth	8.18%	227.64%	-77.29%	-56.78%	4750.64%
Accounts Receivable	0.46	0.51	0.33	0.18	0.25
Inventory	1.82	1.27	1.07	1.29	1.06
Other Current Assets	0.42	0.64	0.38	0.53	1.83
Total Current Assets	13.26	12.19	4.75	15.13	33.5
Net Property, Plant & Equipment	1.07	0.6	0.95	1.4	0.6
Other Long-Term Assets	0.05	0.04	0.04	0.04	0.04
Total Assets	14.38	12.82	5.73	16.57	34.14
Accounts Payable	10.48	5.78	3.11	3.55	3.28
Short-Term Debt	-	-	-	-	0.5
Current Portion of Leases	0.31	0.17	0.38	0.36	0.15
Total Current Liabilities	10.8	5.95	3.49	3.91	3.92
Long-Term Leases	0.1	-	0.16	0.54	0.09
Other Long-Term Liabilities	-	-	-	0.48	0.47
Total Long-Term Liabilities	0.1	-	0.16	1.02	0.56
Total Liabilities	10.9	5.95	3.65	4.93	4.48
Common Stock	288.19	262.6	239.65	235.04	235.04
Additional Paid-in Capital	10.53	10.53	10.53	10.53	10.53
Accumulated Other Comprehensive Income	19.71	19.18	18.24	18	16.64
Retained Earnings	-314.95	-285.43	-266.33	-251.92	-232.54
Total Common Shareholders' Equity	3.49	6.88	2.09	11.64	29.66
Shareholders' Equity	3.49	6.88	2.09	11.64	29.66
Total Liabilities & Equity	14.38	12.82	5.73	16.57	34.14
Total Debt	0.41	0.17	0.54	0.9	0.74
Net Cash (Debt)	10.15	9.6	2.44	12.23	29.63
Net Cash Growth	5.77%	293.40%	-80.05%	-58.72%	-
Net Cash Per Share	0.02	0.04	0.01	0.06	0.37
Book Value	3.49	6.88	2.09	11.64	29.66
Book Value Per Share	0.01	0.03	0.01	0.06	0.37
Tangible Book Value	3.49	6.88	2.09	11.64	29.66
Tangible Book Value Per Share	0.01	0.03	0.01	0.06	0.37